Financhill
Back

Macrogenics Stock Predictions

Macrogenics Stock Forecast

  • Is Macrogenics Stock Undervalued?
    The current Macrogenics [MGNX] share price is $3.77. The Score for MGNX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • MGNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Macrogenics Stock Go Up Next Year?

Data Unavailable

Macrogenics Stock Rating

Data Unavailable

Macrogenics Stock Price History

Is MGNX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
macrogenics.com

52-Week Data

52-Week High:
21.88
52-Week Low:
2.95

Prediction Charts

Market Cap:
236.62M
Price in USD:
3.77
Volume:
622.32K
Beta:
2.02

Technical Analysis

SMA50:
3.64
SMA100:
3.89
SMA200:
8.45
52-Wk Change:
-40.82%

Stock Predictions

  • Is Macrogenics stock public?
    Yes, Macrogenics is a publicly traded company.
  • What is the Macrogenics stock quote today?
    The Macrogenics stock price is 3.77 USD today.
  • How to buy Macrogenics stock online?
    You can buy Macrogenics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 3.60 3.49 3.60 3.48
Oct-28 3.49 3.52 3.64 3.43
Oct-29 3.55 3.33 3.55 3.33
Oct-30 3.51 3.40 3.58 3.21
Oct-31 3.34 3.66 3.71 3.34
Nov-1 3.66 3.87 3.95 3.65
Nov-4 3.87 3.71 3.89 3.61
Nov-5 3.70 3.77 3.85 3.65
Nov-6 4.59 4.18 5.10 4.09
Nov-7 4.12 4.46 4.87 4.09
Nov-8 4.45 4.35 4.54 4.19
Nov-11 4.39 4.39 4.40 4.18
Nov-12 4.38 4.10 4.39 4.01
Nov-13 4.05 3.77 4.16 3.77

Macrogenics Earnings

Data Unavailable

Macrogenics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and a decrease next year of $1.14 per share.

* Macrogenics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.